News Briefs: Boston Sci Settlement; C.R. Bard Scores Patent Victory
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific owes another $30 million to settle more charges related to Guidant ICD issues. C.R. Bard closer to receiving big payout from Gore on patent case. FDA issues a safety alert on St. Jude’s Amplatzer occluder More news briefs.
You may also be interested in...
Expert Urges Companies to Heed Whistleblowers
As manufacturers come under more scrutiny for fraud from the federal government, David Marshall, an attorney who specializes in whistleblower cases, says companies that deal with non-compliance issues early are much more likely to get lenient treatment than those who try covering them up.
Expert Urges Companies to Heed Whistleblowers
As device makers come under more scrutiny for fraud from the federal government, David Marshall, an attorney who specializes in whistleblower cases, says companies that deal with non-compliance issues early are much more likely to get lenient treatment than those who try covering them up.
Research Briefs: Reports On HeartMate II Thromboses, Endurant AAA Graft Durability,Corus CAD Test
Three major teaching hospitals are reporting an unexpected increase in thrombosis in patients implanted with HeartMate II left ventricular assist devices since March 2011. More research news.